US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Niagen Bioscience

2.79

+0.11004.10%

Post-market: 2.790.00000.00%16:10 EDT

Volume:1.57M

Turnover:4.22M

Market Cap:222.21M

PE:14.67

High:2.80

Open:2.72

Low:2.61

Close:2.68

52wk High:8.07

52wk Low:2.61

Shares:79.64M

Float Shares:55.82M

Volume Ratio:2.57

T/O Rate:2.81%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.1901

EPS(LYR):0.2000

ROE:21.80%

ROA:5.44%

PB:2.69

PE(LYR):13.95

Loading ...

Overview Company News Filings

Niagen Rises After U.S., EU Rare Disease Designations for Drug Candidate

Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168

Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (rpd) Designation and European Medicines Agency Orphan Medicinal Product Designation (ompd) for Nb4168 for the Treatment of Ataxia Telangiectasia (a-t)

THOMSON REUTERS

Niagen Bioscience Launches Program to Develop Therapies for Accelerated Aging and Rare Genetic Diseases

MT Newswires Live

Niagen Bioscience launches pharmaceutical program for aging and genetic diseases

Niagen Bioscience initiated with a Buy at Freedom Broker

Niagen Bioscience Shareholders Back Board and Governance Measures

Niagen Bioscience Holds Annual Shareholder Meeting, Elects Directors

Niagen Bioscience - up to $50 Mln of Common Stock May be Sold Under Sales Agreement Dated June 26, 2026 - SEC Filing

THOMSON REUTERS

Niagen Bioscience - May Offer up to $125 Mln of Securities - SEC Filing

THOMSON REUTERS

Top Growth Companies With Strong Insider Ownership For June 2026

Simply Wall St.

Elite Penny Stocks With Cash Strength Backing Big Growth Stories

Simply Wall St.

Niagen Bioscience to present at East Coast IDEAS Investor Conference

Niagen Bioscience renames CERP to Niagen Research Program

Niagen Bioscience Rebrands External Research Program to Strengthen NAD+ Scientific Leadership

Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)

BRIEF-NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims

National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims

THOMSON REUTERS

Niagen Bioscience Earnings Call Highlights Growth Push

Promising Penny Stocks To Consider In May 2026

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/NAGE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NAGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","market":"US","secType":"STK","nameCN":"Niagen Bioscience","latestPrice":2.79,"timestamp":1790971200000,"preClose":2.68,"halted":0,"volume":1568233,"hourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.79,"latestTime":"16:10 EDT","volume":3984,"amount":11115.36,"timestamp":1790971805445,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.04104477611940294,"floatShares":55819168,"shares":79644327,"eps":0.190148,"marketStatus":"Post-Mkt","change":0.11,"latestTime":"10-02 16:50:24 EDT","open":2.72,"high":2.8,"low":2.61,"amount":4218951,"amplitude":0.070896,"askPrice":2.93,"askSize":60,"bidPrice":2.62,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.190148,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790985600000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":2.68,"preHourTrading":{"tag":"盘前","latestPrice":2.75,"preClose":2.68,"latestTime":"09:26 EDT","volume":94,"amount":269.09619699999996,"timestamp":1790947563818,"change":0.07,"changeRate":0.026119,"amplitude":0.119403},"postHourTrading":{"tag":"盘后","latestPrice":2.79,"preClose":2.79,"latestTime":"16:10 EDT","volume":3984,"amount":11115.36,"timestamp":1790971805445,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.565247,"impliedVol":1.2741,"impliedVolPercentile":0.5657},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAGE\",,,,,undefined,":{"symbol":"NAGE","floatShares":55819168,"roa":"5.44%","roe":"21.80%","lyrEps":0.2,"volumeRatio":2.565247,"shares":79644327,"dividePrice":0,"high":2.8,"amplitude":0.070896,"preClose":2.68,"low":2.61,"week52Low":2.61,"pbRate":"2.69","psRate":"1.72","week52High":8.0749,"institutionHeld":0,"latestPrice":2.79,"committee":0.25,"eps":0.190148,"divideRate":0,"volume":1568233,"delay":0,"ttmEps":0.190148,"open":2.72,"prevYearClose":6.36,"prevWeekClose":3.05,"prevMonthClose":2.92,"prevQuarterClose":2.92,"fiveDayClose":3.05,"twentyDayClose":3.11,"sixtyDayClose":3.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"NAGE","fiscalQuarterEnding":"2026/06","expectedEps":0.01,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"post","actualEps":0.01},{"market":"US","date":"2026-05-06","symbol":"NAGE","fiscalQuarterEnding":"2026/03","expectedEps":0.06,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2026-03-04","symbol":"NAGE","fiscalQuarterEnding":"2025/12","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772600400000,"reportTimeType":"post","actualEps":0.03},{"market":"US","date":"2025-11-04","symbol":"NAGE","fiscalQuarterEnding":"2025/09","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.05},{"market":"US","date":"2025-08-06","symbol":"NAGE","fiscalQuarterEnding":"2025/06","expectedEps":0.02,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":0.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAGE","date":"2026-10-01","current":14.672781,"percent":0.041667,"low":13.660897,"twenty":15.718305,"median":25.560781,"eighty":54.52519,"high":80.643552,"avg":34.146256,"sd":19.703479,"marketCap":231535565},"quantilePoints":[{"date":"2025-03-21","current":69.624479,"twenty":69.806742,"median":70.080136,"eighty":70.353531,"marketCap":595289295},{"date":"2025-03-28","current":67.346191,"twenty":68.676711,"median":69.624479,"eighty":70.371757,"marketCap":575809933},{"date":"2025-04-04","current":60.420196,"twenty":62.662031,"median":67.938546,"eighty":69.697384,"marketCap":516592673},{"date":"2025-04-11","current":51.67157,"twenty":54.861173,"median":62.880747,"eighty":69.551574,"marketCap":441791924},{"date":"2025-04-17","current":59.600012,"twenty":54.815607,"median":61.696037,"eighty":69.259953,"marketCap":509580103},{"date":"2025-04-25","current":67.255059,"twenty":55.043436,"median":62.151694,"eighty":68.530901,"marketCap":575030758},{"date":"2025-05-02","current":68.895427,"twenty":55.954751,"median":62.880747,"eighty":69.442216,"marketCap":589055899},{"date":"2025-05-09","current":51.710369,"twenty":55.954751,"median":65.022337,"eighty":70.535794,"marketCap":729374756},{"date":"2025-05-16","current":58.761783,"twenty":54.815607,"median":62.789615,"eighty":69.71561,"marketCap":828834951},{"date":"2025-05-23","current":56.859021,"twenty":55.043436,"median":61.650471,"eighty":69.624479,"marketCap":801996485},{"date":"2025-05-30","current":60.552618,"twenty":55.242319,"median":61.364091,"eighty":69.478669,"marketCap":854094682},{"date":"2025-06-06","current":64.414107,"twenty":55.822209,"median":61.604905,"eighty":69.296406,"marketCap":908560979},{"date":"2025-06-13","current":79.132535,"twenty":56.409541,"median":62.698483,"eighty":70.55402,"marketCap":1116164400},{"date":"2025-06-20","current":77.117845,"twenty":56.623974,"median":63.647427,"eighty":71.912091,"marketCap":1087747202},{"date":"2025-06-27","current":77.341699,"twenty":56.791865,"median":65.523561,"eighty":75.181504,"marketCap":1090904668},{"date":"2025-07-03","current":71.129739,"twenty":57.426855,"median":65.645306,"eighty":75.483707,"marketCap":1003284974},{"date":"2025-07-11","current":65.981088,"twenty":58.471876,"median":66.48476,"eighty":75.192697,"marketCap":930663244},{"date":"2025-07-18","current":57.950311,"twenty":58.471876,"median":65.645306,"eighty":75.114348,"marketCap":817389135},{"date":"2025-07-25","current":51.87826,"twenty":56.758286,"median":65.022337,"eighty":74.190401,"marketCap":731742856},{"date":"2025-08-01","current":52.325969,"twenty":55.224884,"median":64.358143,"eighty":72.732275,"marketCap":738057789},{"date":"2025-08-08","current":43.320593,"twenty":54.318273,"median":62.947882,"eighty":72.15947,"marketCap":768030786},{"date":"2025-08-15","current":43.771379,"twenty":53.985743,"median":62.607352,"eighty":71.628921,"marketCap":776022782},{"date":"2025-08-22","current":44.041851,"twenty":52.415511,"median":61.650471,"eighty":71.37484,"marketCap":780817979},{"date":"2025-08-29","current":44.267244,"twenty":51.68709,"median":61.280145,"eighty":71.129739,"marketCap":784813977},{"date":"2025-09-05","current":42.013311,"twenty":50.71606,"median":60.552618,"eighty":71.083855,"marketCap":744853999},{"date":"2025-09-12","current":43.365671,"twenty":45.745824,"median":60.318517,"eighty":70.845641,"marketCap":768829986},{"date":"2025-09-19","current":45.709762,"twenty":45.222912,"median":59.50888,"eighty":70.6087,"marketCap":810388363},{"date":"2025-09-26","current":42.419019,"twenty":45.024566,"median":58.520194,"eighty":70.371757,"marketCap":752046795},{"date":"2025-10-03","current":33.268051,"twenty":44.46559,"median":56.887002,"eighty":69.697384,"marketCap":589809282},{"date":"2025-10-10","current":34.079467,"twenty":44.02382,"median":56.607185,"eighty":69.623328,"marketCap":604194874},{"date":"2025-10-17","current":33.448366,"twenty":43.66319,"median":55.29204,"eighty":69.583421,"marketCap":593006080},{"date":"2025-10-24","current":33.448366,"twenty":43.41075,"median":54.929521,"eighty":69.405763,"marketCap":593006080},{"date":"2025-10-31","current":32.050928,"twenty":43.28453,"median":54.228731,"eighty":69.187048,"marketCap":568230894},{"date":"2025-11-07","current":25.87441,"twenty":42.455082,"median":54.050915,"eighty":68.822522,"marketCap":528588317},{"date":"2025-11-14","current":27.403352,"twenty":42.022327,"median":53.333314,"eighty":68.390298,"marketCap":559823081},{"date":"2025-11-21","current":26.30565,"twenty":34.151593,"median":52.437896,"eighty":67.731548,"marketCap":537398122},{"date":"2025-11-28","current":26.540872,"twenty":33.854074,"median":52.018169,"eighty":67.346191,"marketCap":542203471},{"date":"2025-12-05","current":26.266446,"twenty":33.628681,"median":51.67157,"eighty":67.255059,"marketCap":536597231},{"date":"2025-12-12","current":25.992021,"twenty":33.448366,"median":50.903505,"eighty":67.255059,"marketCap":530990991},{"date":"2025-12-19","current":25.482373,"twenty":32.772186,"median":49.393282,"eighty":66.988433,"marketCap":520579403},{"date":"2025-12-26","current":25.913613,"twenty":32.474667,"median":46.160548,"eighty":66.182557,"marketCap":529389208},{"date":"2026-01-02","current":24.933522,"twenty":30.002996,"median":45.709762,"eighty":65.94751,"marketCap":509366924},{"date":"2026-01-09","current":25.717595,"twenty":27.520963,"median":45.43929,"eighty":65.757233,"marketCap":525384751},{"date":"2026-01-16","current":24.737504,"twenty":27.019156,"median":45.168818,"eighty":65.594939,"marketCap":505362467},{"date":"2026-01-23","current":24.619893,"twenty":26.909386,"median":44.627874,"eighty":65.546241,"marketCap":502959792},{"date":"2026-01-30","current":23.482987,"twenty":26.540872,"median":44.492638,"eighty":65.122582,"marketCap":479733942},{"date":"2026-02-06","current":20.111473,"twenty":26.282128,"median":44.267244,"eighty":64.478311,"marketCap":410857283},{"date":"2026-02-13","current":19.954658,"twenty":25.944976,"median":44.008043,"eighty":64.391721,"marketCap":407653717},{"date":"2026-02-20","current":19.366604,"twenty":25.843047,"median":43.816458,"eighty":64.134289,"marketCap":395640346},{"date":"2026-02-27","current":20.307491,"twenty":25.623506,"median":43.591065,"eighty":63.1941,"marketCap":414861740},{"date":"2026-03-06","current":23.545172,"twenty":25.529418,"median":43.41075,"eighty":62.988163,"marketCap":409262188},{"date":"2026-03-13","current":22.252496,"twenty":25.411807,"median":43.320593,"eighty":62.862521,"marketCap":386792892},{"date":"2026-03-20","current":21.88316,"twenty":25.058974,"median":43.095199,"eighty":62.753162,"marketCap":380373093},{"date":"2026-03-27","current":20.636651,"twenty":24.761026,"median":42.599334,"eighty":62.487416,"marketCap":358706271},{"date":"2026-04-02","current":20.867486,"twenty":24.619893,"median":42.419019,"eighty":62.007672,"marketCap":362718645},{"date":"2026-04-10","current":20.682818,"twenty":24.345467,"median":42.035851,"eighty":61.696037,"marketCap":359508746},{"date":"2026-04-17","current":21.836993,"twenty":23.875024,"median":35.567063,"eighty":61.604905,"marketCap":379570618},{"date":"2026-04-24","current":21.836993,"twenty":23.545172,"median":34.102007,"eighty":61.448036,"marketCap":379570618},{"date":"2026-05-01","current":21.836993,"twenty":23.175836,"median":33.854074,"eighty":61.280145,"marketCap":379570618},{"date":"2026-05-08","current":18.041368,"twenty":22.760333,"median":33.696298,"eighty":61.168218,"marketCap":336236974},{"date":"2026-05-15","current":16.273169,"twenty":22.34483,"median":33.493445,"eighty":60.552618,"marketCap":303283042},{"date":"2026-05-22","current":16.230344,"twenty":22.248072,"median":33.448366,"eighty":60.552618,"marketCap":302484929},{"date":"2026-05-29","current":16.444465,"twenty":22.012428,"median":33.155355,"eighty":60.44668,"marketCap":306475495},{"date":"2026-06-05","current":14.988445,"twenty":21.873927,"median":32.772186,"eighty":60.257509,"marketCap":279339644},{"date":"2026-06-12","current":14.688676,"twenty":21.735571,"median":32.546792,"eighty":59.723377,"marketCap":273752851},{"date":"2026-06-18","current":14.431731,"twenty":21.468256,"median":32.208703,"eighty":59.545333,"marketCap":268964171},{"date":"2026-06-26","current":14.174786,"twenty":20.98752,"median":28.148222,"eighty":59.396403,"marketCap":264175492},{"date":"2026-07-02","current":14.260435,"twenty":20.867486,"median":27.834592,"eighty":59.097565,"marketCap":265771718},{"date":"2026-07-10","current":14.945621,"twenty":20.636651,"median":27.324945,"eighty":58.568512,"marketCap":278541531},{"date":"2026-07-17","current":14.560203,"twenty":20.370149,"median":27.050519,"eighty":58.147287,"marketCap":271358511},{"date":"2026-07-24","current":13.660897,"twenty":20.127155,"median":26.95251,"eighty":57.524987,"marketCap":254598133},{"date":"2026-07-31","current":14.21761,"twenty":20.033066,"median":26.893705,"eighty":56.881406,"marketCap":264973605},{"date":"2026-08-07","current":15.07415,"twenty":19.767151,"median":26.540872,"eighty":56.825443,"marketCap":241050726},{"date":"2026-08-14","current":15.123736,"twenty":19.424638,"median":26.403659,"eighty":56.657552,"marketCap":241843656},{"date":"2026-08-21","current":15.619596,"twenty":18.243689,"median":26.266446,"eighty":56.409541,"marketCap":249772956},{"date":"2026-08-28","current":15.917112,"twenty":16.632891,"median":26.011623,"eighty":55.822209,"marketCap":254530536},{"date":"2026-09-04","current":15.421252,"twenty":16.410206,"median":25.913613,"eighty":55.269655,"marketCap":246601236},{"date":"2026-09-11","current":15.049357,"twenty":16.273169,"median":25.835206,"eighty":55.180113,"marketCap":240654261},{"date":"2026-09-18","current":14.826219,"twenty":16.059048,"median":25.737197,"eighty":55.043436,"marketCap":237086075},{"date":"2026-09-25","current":14.925392,"twenty":15.844927,"median":25.560781,"eighty":54.815607,"marketCap":238671936},{"date":"2026-10-01","current":14.479117,"twenty":15.718305,"median":25.560781,"eighty":54.52519,"marketCap":231535565}],"updateTime":1790974224252},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAGE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651111777","title":"Niagen Rises After U.S., EU Rare Disease Designations for Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111777","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111777?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:49","pubTimestamp":1783946985,"startTime":"0","endTime":"0","summary":"BUZZ-Niagen rises after U.S., EU rare disease designations for drug candidate** Shares of biotech firm Niagen BioscienceNAGE.Orise 2.6% to $3.47 premarket** Co says its experimental drug, NB4168, rece","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nL4N43F12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111259","title":"Niagen Bioscience receives exclusive U.S. RPD, EMA OMPD for NB4168","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111259?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:35","pubTimestamp":1783946107,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced that the U.S. Food & Drug Administration, FDA, granted Rare Pediatric Disease, RPD, Designation for its propriet...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-receives-exclusive-u-s-rpd-ema-ompd-for-nb4168-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-receives-exclusive-u-s-rpd-ema-ompd-for-nb4168-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","BK4097","RPD","LABU","BK4081","EMA","BK4585","BK4121","LU1878469433.USD","NAGE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651111606","title":"Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (rpd) Designation and European Medicines Agency Orphan Medicinal Product Designation (ompd) for Nb4168 for the Treatment of Ataxia Telangiectasia (a-t)","url":"https://stock-news.laohu8.com/highlight/detail?id=2651111606","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651111606?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:32","pubTimestamp":1783945920,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nTUA13G7ZY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649348999","title":"Niagen Bioscience Launches Program to Develop Therapies for Accelerated Aging and Rare Genetic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2649348999","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649348999?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:17","pubTimestamp":1783516678,"startTime":"0","endTime":"0","summary":"Niagen Bioscience  said Wednesday that its NAD Pharmaceuticals unit will undertake a pharmaceutical program to develop therapies for accelerated aging and rare genetic diseases.The program will primarily focus on how NAD+, a coenzyme vital for energy metabolism, DNA repair, mitochondrial function and cellular stress responses, modulates in rare diseases for which DNA misrepair and mitochondrial dysfunction are foundational underlying causes, the company said.Niagen said that NB4168, a derivative of the NAD+ precursor nicotinamide riboside, is the first investigational pharmaceutical product candidate within the program, with Ataxia Telangiectasia as the initial indication.Shares of the company were up 1.5% in Wednesday's premarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649996849","title":"Niagen Bioscience launches pharmaceutical program for aging and genetic diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2649996849","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649996849?lang=en_us&edition=fundamental","pubTime":"2026-07-08 20:40","pubTimestamp":1783514425,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) formally launched the first drug candidate of NAD Pharmaceuticals, its wholly owned subsidiary focused on developing thera...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-launches-pharmaceutical-program-for-aging-and-genetic-diseases-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-launches-pharmaceutical-program-for-aging-and-genetic-diseases-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649067608","title":"Niagen Bioscience initiated with a Buy at Freedom Broker","url":"https://stock-news.laohu8.com/highlight/detail?id=2649067608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649067608?lang=en_us&edition=fundamental","pubTime":"2026-07-07 03:10","pubTimestamp":1783365021,"startTime":"0","endTime":"0","summary":"Freedom Broker analyst Ilya Zubkov initiated coverage of Niagen Bioscience (NAGE) with a Buy rating and $9 price target The firm calls Niagen “a be...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-initiated-with-a-buy-at-freedom-broker-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647075723","title":"Niagen Bioscience Shareholders Back Board and Governance Measures","url":"https://stock-news.laohu8.com/highlight/detail?id=2647075723","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647075723?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:03","pubTimestamp":1782767001,"startTime":"0","endTime":"0","summary":"Niagen Bioscience ( ($NAGE) ) just unveiled an update. At Niagen Bioscience’s 2026 Annual Meeting of Stockholders, shareholders elected eight direc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-shareholders-back-board-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-shareholders-back-board-and-governance-measures?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647302554","title":"Niagen Bioscience Holds Annual Shareholder Meeting, Elects Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2647302554","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647302554?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:31","pubTimestamp":1782765095,"startTime":"0","endTime":"0","summary":"Niagen Bioscience holds annual shareholder meeting, elects directorsNiagen Bioscience held its 2026 annual meeting.Shareholders backed the appointment of Crowe LLP as independent registered public acc","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nNDLbFn1kV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647745378","title":"Niagen Bioscience - up to $50 Mln of Common Stock May be Sold Under Sales Agreement Dated June 26, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2647745378","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647745378?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:03","pubTimestamp":1782727423,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43104I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647337857","title":"Niagen Bioscience - May Offer up to $125 Mln of Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2647337857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647337857?lang=en_us&edition=fundamental","pubTime":"2026-06-29 18:03","pubTimestamp":1782727423,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43104I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645021853","title":"Top Growth Companies With Strong Insider Ownership For June 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021853","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021853?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:05","pubTimestamp":1782126345,"startTime":"0","endTime":"0","summary":"The United States market has demonstrated robust performance, climbing 1.4% in the last week and achieving a 26% increase over the past year, with earnings projected to grow by 19% annually. In this thriving environment, growth companies with strong insider ownership can be particularly appealing as they often align management interests with those of shareholders, potentially enhancing long-term value creation.","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abeo/abeona-therapeutics/news/top-growth-companies-with-strong-insider-ownership-for-june","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-abeo/abeona-therapeutics/news/top-growth-companies-with-strong-insider-ownership-for-june","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ABEO","YSS","BK4183","BK4121","NAGE","BK4187","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644771568","title":"Elite Penny Stocks With Cash Strength Backing Big Growth Stories","url":"https://stock-news.laohu8.com/highlight/detail?id=2644771568","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644771568?lang=en_us&edition=fundamental","pubTime":"2026-06-17 14:26","pubTimestamp":1781677567,"startTime":"0","endTime":"0","summary":"Penny stocks are often written off as lottery tickets, but rising global rate pressures, uneven inflation trends and mixed growth data are putting a premium on strong balance sheets and access to cash. That is where the Elite Penny Stocks screener stands out. It filters for lower priced stocks that actually look funded to pursue their growth plans, rather than relying on hope and dilution. For investors who want exposure to higher risk and higher potential ideas without guessing blindly, this...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/nasdaq-grab/grab-holdings/news/elite-penny-stocks-with-cash-strength-backing-big-growth-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/nasdaq-grab/grab-holdings/news/elite-penny-stocks-with-cash-strength-backing-big-growth-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4547","BK4183","BK4230","SG9999001135.SGD","LU2362541513.USD","LU1242518857.USD","SG9999002406.SGD","CLOV","GRAB","SG9999013460.SGD","BK4121","BK4122","LU2362541273.HKD","SG9999002679.SGD","BK4154","SG9999013478.USD","LU2045819591.USD","SG9999013486.USD","SGXZ58947870.SGD","SG9999006266.SGD","BK4022","SG9999002414.USD",".IXIC","LU1839390173.USD","SG9999002620.SGD","LU2362540622.SGD","LU0532188223.SGD","LU1242518931.SGD","SG9999002604.SGD","NAGE","LU2125910500.SGD","LU0210637038.USD","GRAG","LU0441851309.USD","LU0979878070.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640904962","title":"Niagen Bioscience to present at East Coast IDEAS Investor Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640904962","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640904962?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:37","pubTimestamp":1780490237,"startTime":"0","endTime":"0","summary":"Niagen Bioscience management will present at the East Coast IDEAS Investor Conference on June 11, 2026, in New York.CEO Rob Fried is scheduled to present from 2:40 p.m. to 3:15 p.m. ET.CFO Ozan Pamir will attend for one-on-one meetings with institutional investors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Niagen Bioscience Inc. published the original content used to generate this news brief via Business Wire  on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL6wB1jx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4183","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640794499","title":"Niagen Bioscience renames CERP to Niagen Research Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2640794499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640794499?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:25","pubTimestamp":1780413933,"startTime":"0","endTime":"0","summary":"Niagen Bioscience (NAGE) announced the official renaming of the ChromaDex External Research Program, CERP, to the Niagen Research Program, reflecti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-renames-cerp-to-niagen-research-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/niagen-bioscience-renames-cerp-to-niagen-research-program-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE","BK4121","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162124470","title":"Niagen Bioscience Rebrands External Research Program to Strengthen NAD+ Scientific Leadership","url":"https://stock-news.laohu8.com/highlight/detail?id=1162124470","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162124470?lang=en_us&edition=fundamental","pubTime":"2026-06-02 23:11","pubTimestamp":1780413111,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, a global authority in the science of NAD+ (nicotinamide adenine dinucleotide), has announced the formal renaming of its widely recognized \"ChromaDex External Research Program\" to...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NAD","NAGE","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638660086","title":"Analysts Are Bullish on Top Healthcare Stocks: Niagen Bioscience (NAGE), Guardant Health (GH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638660086","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638660086?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:40","pubTimestamp":1779968405,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Niagen Bioscience (NAGE), Guardant Health (GH) and B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-niagen-bioscience-nage-guardant-health-gh-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NAGE","BK4585","BK4551","GH","BK4121","BK4535","BK4196","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637584453","title":"BRIEF-NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2637584453","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637584453?lang=en_us&edition=fundamental","pubTime":"2026-05-22 00:16","pubTimestamp":1779380214,"startTime":"0","endTime":"0","summary":"BRIEF-NARB Recommends Niagen Modify/Discontinue Certain Tru Niagen Nad+ Dietary Supplement ClaimsMay 21 (Reuters) - National Advertising Review Board:NATIONAL ADVERTISING REVIEW BOARD RECOMMENDS NIAGE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAGE","BK4183","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637332991","title":"National Advertising Review Board Recommends Niagen Modify or Discontinue Certain Tru Niagen Nad+ Dietary Supplement Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2637332991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637332991?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:31","pubTimestamp":1779373915,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y12Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","BK4121","NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636181718","title":"Niagen Bioscience Earnings Call Highlights Growth Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2636181718","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636181718?lang=en_us&edition=fundamental","pubTime":"2026-05-20 13:40","pubTimestamp":1779255622,"startTime":"0","endTime":"0","summary":"Niagen Bioscience, Inc. (($NAGE)) has held its Q1 earnings call. Read on for the main highlights of the call. Niagen Bioscience’s latest earnings c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/niagen-bioscience-earnings-call-highlights-growth-push-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAGE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635896510","title":"Promising Penny Stocks To Consider In May 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2635896510","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635896510?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:05","pubTimestamp":1778843111,"startTime":"0","endTime":"0","summary":"The United States market has shown impressive growth, with a 1.1% increase over the last week and a substantial 27% rise over the past year, alongside expectations for earnings to grow by 17% annually in the coming years. Penny stocks, while an older term, continue to capture attention as they often represent smaller or newer companies that provide growth opportunities at lower price points. By focusing on those with strong financial health and solid fundamentals, investors can uncover...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ltrn/lantern-pharma/news/promising-penny-stocks-to-consider-in-may-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4166","FINV","ZJK","BK4209","LU1235295612.USD","BK4139","BK4509","BK4505","VFF","NAGE","BK4121","HLP","LU1046422090.SGD","LX","BK4531","LTRN","TUYA","BK4189","III","BK4023","BK4526","BK4161","BK4579","BABB","LU0049112450.USD","BK4183","BK4006","SPRO","BK4134"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":90,"code":"91000000","status":"200"}]}}